Best Osimertinib Podcasts (2024)

1
202 - What I Eat In A Week 34:28

2d ago34:28

34:28

Mastering Meal Planning: Insights for Sustainable Nutrition Dive into the world of strategic meal planning with Amy Ledin as she unveils key insights for success. Explore practical strategies, meal ideas, and mindful eating tips designed to revolutionize your approach to nutrition. From managing cravings to optimizing meal timing, discover the secr…

1
Oncotarget Sponsors 19th International p53 Workshop in Italy 2:06

3d ago2:06

2:06

BUFFALO, NY- April 29, 2024 – Oncotarget is a contributing #sponsor at the 19th International p53 Workshop, organized by the International Center for Genetic Engineering and Biotechnology (ICGEB), which takes place from May 13–16, 2024, in Trieste, Italy.“Groundbreaking research and cutting-edge advancements in the field of the most studied human g…

1
Podcast on the IWGDF 2023 Guidelines on the Prevention of Foot Ulcers in Persons with Diabetes 7:51

3d ago7:51

7:51

In this podcast, the Chair and Secretary of the 2023 International Working Group on the Diabetic Foot (IWGDF) guideline on prevention for diabetes-related foot ulcers. This podcast aims to highlight the importance of ulcer prevention and the opportunities to incorporate recommendations into clinical practice. This podcast is published open access i…

1
Podcast on Emerging Treatment Options for Pediatric Patients with ALK-Positive Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumors 23:28

3d ago23:28

23:28

Anaplastic large cell lymphoma (ALCL) and inflammatory myofibroblastic tumor (IMT) are rare cancers observed predominantly in children and young adults. ALCL accounts for 10–15% of all pediatric non-Hodgkin lymphomas and is commonly diagnosed at an advanced stage of disease. This podcast provides an overview of ALK-positive ALCL and IMT. The author…

1
Real-World Data on Therapies for Relapsed or Refractory Multiple Myeloma: Key Data from ASH 2023—A Podcast 33:55

6d ago33:55

33:55

In this podcast, the authors reviewed and discussed seven abstracts presented at the 65th Annual Meeting of the American Society of Hematology, focusing on B cell maturation antigen-directed therapies, emphasizing the value of real-world data (RWD) in treatment decision-making, and suggesting how RWD can help advance multiple myeloma research. Thes…

1
Identification of a Patient Suitable for CAR-T Cell Therapy in the Outpatient Setting: A Vodcast and Case Example 21:31

6d ago21:31

21:31

Chimeric antigen receptor T cell (CAR-T) therapies targeting the CD19 antigen have been associated with high and durable response rates in patients with diffuse large B cell lymphoma (DLBCL). In this podcast, Dr. Foley and Dr. Kuruvilla discuss the case of a patient presenting with the ideal profile for CAR-T cell therapy referral whilst also deter…

1
201 - Managing Stress and Leveraging the Body's Energy for Healing With Isaac Ho 59:08

9d ago59:08

59:08

In this enlightening episode, Amy Ledin welcomes back Isaac Ho for a deep dive into understanding the intricate relationship between our emotions, physical health, and overall well-being. Isaac, with 20 years of experience as a trainer and therapist, shares his journey and insights into how our bodies respond to stress and the significance of tunin…

1
Novel Therapeutic Bispecific Antibodies for B-cell Lymphoma 3:17

16d ago3:17

3:17

BUFFALO, NY- April 16, 2024 – A new #researchpaper was #published in Oncotarget's Volume 15 on April 12, 2024, entitled, “Novel therapeutic bispecific antibodies for B-cell lymphoma targeting IgM and other antigens on the B-cell surface.”The B-cell receptor regulates B-cell proliferation and apoptosis. Aberrations in BCR signaling are associated wi…

1
200 - Overcoming Emotional Immaturity with Dr. Nicole LePera (The Holistic Psychologist) 1:06:47

17d ago1:06:47

1:06:47

Host Amy Ledin delves into the transformative power of emotional maturity with Dr. Nicole LePera, the Holistic Psychologist. This insightful episode explores the impact of childhood experiences, the significance of self-care in managing triggers, the effectiveness of future self-journaling for rewiring habits, and the profound benefits of community…

1
Synergistic Effects of Drug Combinations Targeting AML Cells 5:48

21d ago5:48

5:48

Acute myeloid leukemia (AML) is a cancer characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells. ABT199, also known as venetoclax, is a targeted therapy that inhibits the BCL-2 protein, which is often overexpressed in AML cells and contributes to the…

1
Exploring the Role of MIA-602 in Overcoming Doxorubicin-resistance in Acute Myeloid Leukemia 2:52

23d ago2:52

2:52

BUFFALO, NY- April 10, 2024 – A new #researchpaper was #published in Oncotarget's Volume 15 on April 8, 2024, entitled, “Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia.”Acute myeloid leukemia (AML) is characterized by the rapid proliferation of mutagenic hematopoietic progenitors in the …

1
The Importance of Biomarker Testing in the Treatment of Advanced Non-Small Cell Lung Cancer: A Podcast 32:07

1M ago32:07

32:07

Panel-based sequencing platforms are becoming more accessible, and molecular biomarker analysis of circulating tumor DNA is becoming more common. In this podcast, authors discuss the importance of biomarker testing in advanced non-small cell lung cancer (NSCLC) and explore topics such as testing methodologies, effect of biomarker testing on patient…

1
Identifying Biomarkers for Predicting Paclitaxel Response 5:48

1M ago5:48

5:48

Cancer therapy has come a long way from its one-size-fits-all beginning to the awakening era of personalized medicine. This change has been largely driven by the discovery of biomarkers. Biomarkers can help refine patient selection for specific therapies. A blend of causal and correlative approaches is needed to elucidate the full potential of biom…

1
Durvalumab and Tremelimumab Before Surgery in Patients With HR+/HER2-negative Breast Cancer 3:15

1M ago3:15

3:15

BUFFALO, NY- March 27, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on March 19, 2024, entitled, “Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II–III breast cancer.”In this new study, researchers Haven R. Garber, Sreyashi Basu, Sonali Jindal, Zhong He, Khoi Chu, …

1
ABT199/Venetoclax Synergism With Thiotepa in Acute Myeloid Leukemia (AML) Cells 3:21

1M ago3:21

3:21

BUFFALO, NY- March 25, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on March 14, 2024, entitled, “ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells.”ABT199/venetoclax, an inhibitor of the pro-survival BCL-2 protein, has improved AML treatment. Its effica…

1
The Why, What and Where Podcast on the Updated 2023 IWGDF Guideline on Offloading Treatments for Diabetes-Related Foot Ulcers 9:47

1M ago9:47

9:47

In this podcast the Chair and Secretary of the 2023 International Working Group on the Diabetic Foot (IWGDF) guideline on offloading treatments for diabetes-related foot ulcers briefly discuss why we need offloading treatments for people with diabetes-related foot ulcers, what the new international offloading guideline recommends, and where offload…

1
199 - The Slow Identity Killer and How to Fix That Today 22:43

1M ago22:43

22:43

Explore the journey of self-recovery with Amy Ledin in 'The Slow Identity Killer,' where she tackles the challenges of losing one's sense of self through life's unpredictability's. She reveals her personal struggle through a season of upheaval, including a significant loss—leading to a disruption of routine and confidence. Discover Amy's raw insigh…

1
Podcast on How to Classify Foot Ulcers in People with Diabetes (2023 Update of the IWGDF Guidelines on Classification) 12:47

1M ago12:47

12:47

In this podcast, the Chair and Secretary of the 2023 update of the International Working Group of the Diabetic Foot (IWGDF) guidelines on Classification discuss the results of update to the guidelines addressing the use of systems to classify foot ulcers in people with diabetes in routine clinical practice. This podcast is published open access in …

1
Current and Emerging Treatment Options for Patients with Metastatic EGFR-Mutated Non-small Cell Lung Cancer After Progression on Osimertinib and Platinum-Based Chemotherapy: A Podcast Discussion 30:15

1M ago30:15

30:15

Patients with metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) are widely treated with osimertinib, the preferred first-line treatment option. However, disease progression inevitably occurs, driven by EGFR-dependent or EGFR-independent mechanisms of resistance. Platinum-based chemotherapy is the recommen…

1
Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2− Metastatic Breast Cancer: A Podcast 15:26

1M ago15:26

15:26

In this podcast, authors discuss how to ensure that individual patients’ needs and concerns are addressed when it comes to shared decision-making on treatment for metastatic breast cancer. Including an overview of different approaches for initial consultations, strategies for tailoring conversations based on a patient’s background or health literac…

1
The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC): A Podcast 35:25

1M ago35:25

35:25

Authors Dr Peter Black and Dr Bernie Eigl aim to provide an overview of the non-muscle-invasive bladder cancer (NMIBC) landscape with a focus on high-risk NMIBC. This includes understanding the diagnosis and current treatment approaches with a focus on the medical needs and high-risk NMIBC treatment, highlighting the potential challenges associated…

1
A Podcast on Pre- or Perioperative Chemoimmunotherapy for Stage III Non-Small Cell Lung Cancer: Shared Agreement from the Thoracic Surgeon and Oncologist Perspectives 26:33

1M ago26:33

26:33

In this podcast, authors Dr Luca Bertolaccini and Dr Giulio Metro touch upon the need for a standard definition of resectability in patients with resectable stage III non-small cell lung cancer (NSCLC). This podcast gives the perspectives of a thoracic surgeon and an oncologist, and suggests a shared agreement between two of the main actors involve…

1
Optimizing Real-World Outcomes in High-Risk Relapsed/Refractory (r/r) FL with CAR-T Cell Therapy: A Vodcast and Case Example 10:35

1M ago10:35

10:35

In this podcast, author Dr Kai Hübel discussed a case of a patient with high-risk relapse follicular lymphoma. This discussion outlines the potential effectiveness of chimeric antigen receptor (CAR)-T cell therapy in relapsed/refractory follicular lymphoma. This podcast is adapted from a vodcast article published open access in Oncology and Therapy…

1
198 - Proven Mindset to Transforming Fitness From Within With Jared Hamilton 38:05

1M ago38:05

38:05

Challenge conventional wisdom on fat loss with a fresh perspective that prioritizes mental and emotional health as the foundation for physical change. This episode Amy discusses with Jared the critical role of addressing underlying issues like binge eating, emotional eating, and self-sabotage before embarking on a weight loss journey. Learn about t…

1
Analytical Validation of an Ultra-sensitive Personalized Circulating Tumor DNA Assay: NeXT Personal® 3:18

1M ago3:18

3:18

BUFFALO, NY- March 20, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on March 14, 2024, entitled, “Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay.”In this new study, researchers Josette Northcott, Gabor Bartha, Jason Harris, Conan Li, Fabio C.P. Navarro, Rachel Marty Pyke…

1
“From Osimertinib to Preemptive Combinations” by Dr. Blagosklonny 1:55

1M ago1:55

1:55

BUFFALO, NY- March 19, 2024 – A new #research perspective was #published by Mikhail V. Blagosklonny M.D., Ph.D., from Roswell Park Comprehensive Cancer Center in Oncotarget's Volume 15 on March 15, 2024, entitled, “From osimertinib to preemptive combinations.”“Here, I suggest that while first-line osimertinib extends median progression-free surviva…

1
A New Antibody Capture Method Reveals G-quadruplex Landscape and its Regulation 3:32

2M ago3:32

3:32

BUFFALO, NY- March 18, 2024 – A new #researchpaper was #published in Oncotarget's Volume 15 on March 14, 2024, entitled, “G-quadruplex landscape and its regulation revealed by a new antibody capture method.”In this new study, researchers Subhamoy Datta, Manthan Patel, Chakkarai Sathyaseelan, Chandrama Ghosh, Akanksha Mudgal, Divyesh Patel, Thenmala…

1
197 - How To Keep Your Diet On Track Anywhere with Sara Frenza 39:05

2M ago39:05

39:05

Learn how to navigate the challenges of staying healthy while traveling. Amy and Sara, both fitness coaches, discuss the nuances of traveling without compromising on their health goals. They cover practical advice on planning, restraint, and making informed choices. This episode is packed with real-world strategies for anyone looking to maintain th…

1
Antitumor Effects of Sacituzumab Govitecan Plus Platinum-Based Chemotherapy 5:13

2M ago5:13

5:13

The relentless search for effective cancer therapies has led to numerous breakthroughs in drug discovery and development. Advancements have emerged in recent years through the promising avenue of combination therapy, where two or more drugs are used synergistically to enhance their collective therapeutic effect. This strategy has shown significant …

1
196 - Plastic Surgery: I Got My Implants Put Back In 20:23

2M ago20:23

20:23

Amy revisits her journey with breast implants, sharing the unexpected turn of deciding to have them reinserted after previous removal due to concerns about breast implant illness. With raw honesty, she explores the intricate balance between physical appearance and mental health, offering a nuanced perspective on cosmetic surgery. This episode unpac…

1
Oncotarget at AACR Annual Meeting 2024 1:31

2M ago1:31

1:31

BUFFALO, NY- March 11, 2024 – Impact Journals publishes #scholarly journals in the #biomedical sciences with a focus on all areas of cancer and aging research. Oncotarget is one of the most prominent journals published by Impact Journals. Impact Journals will be participating as an exhibitor at the American Association for Cancer Research (AACR) An…

1
195 - How Emotional Energy Affects Your Health 1:05:25

2M ago1:05:25

1:05:25

Coach and Therapist, Isaac Ho shares the journey of uncovering the hidden links between past traumas and physical health issues. Through personal experiences and professional insights, this episode sheds light on how unresolved emotional pain can manifest in the body. It delves into the transformative power of holistic healing practices, emphasizin…

1
Inotuzumab in Older Patients with Newly Diagnosed Acute Lymphoblastic Leukemia — A Podcast 34:33

2M ago34:33

34:33

In this podcast, Elias Jabbour from the University of Texas MD Anderson Cancer Center, Houston, TX, and Matthias Stelljes Universitätsklinikum Münster, Münster, Germany summarize and highlight some of the recent findings on the use of inotuzumab ozogamicin as induction therapy for older adults with newly diagnosed acute lymphoblastic leukemia (ALL)…

1
194 - How to Build A New Identity 13:44

2M ago13:44

13:44

Amy Ledin raises an intriguing question at the heart of today's discussion: 'What new habits are now a part of your daily life that weren't here before?' In this thought-provoking episode, Amy discusses the journey of evolving one's identity to foster a healthier, more fulfilling life. She shares insights into the psychological shifts necessary for…

1
GZ17-6.02 With Proteasome Inhibitors Kills Multiple Myeloma Cells 3:38

2M ago3:38

3:38

BUFFALO, NY- March 6, 2024 – A new #researchpaper was #published in Oncotarget's Volume 15 on March 5, 2024, entitled, “GZ17-6.02 interacts with proteasome inhibitors to kill multiple myeloma cells.”In this new study, researchers Laurence Booth, Jane L. Roberts, Cameron West, and Paul Dent from Virginia Commonwealth University and Genzada Pharmaceu…

1
Sacituzumab Govitecan Plus Platinum-based Chemotherapy in Breast, Bladder, and Lung Carcinomas 3:12

2M ago3:12

3:12

BUFFALO, NY- March 4, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on February 22, 2024, entitled, “Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas.”Sacituzumab govitecan (SG) is an antibody-drug conjugat…

1
A Patient-Centered Approach to Vernal Keratoconjunctivitis (VKC): A Podcast 35:09

2M ago35:09

35:09

This podcast is published open access in Ophthalmology and Therapy and is fully citeable. You can access the original published podcast article through the Ophthalmology and Therapy website and by using this link. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4…

1
193 - New Season, New Chapter - Back in Canada 13:56

2M ago13:56

13:56

Amy Ledin delves into the complexities of her family's significant move back to Canada, shedding light on the emotional and logistical challenges faced together. From tackling immigration hurdles to confronting the difficulties of reuniting their family across borders, Amy shares the story of their journey with honesty and vulnerability. This episo…

1
BRCA1 and BRCA2 in a Cohort of Ovarian Cancer Patients From the Salento Peninsula 3:31

2M ago3:31

3:31

BUFFALO, NY- February 28, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on February 22, 2024, entitled, “Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health.”In this new exploratory and descriptive study, researc…

1
GZ17-6.02 With Bexarotene Kills Mycosis Fungoides Cells 3:32

2M ago3:32

3:32

BUFFALO, NY- February 26, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on February 8, 2024, entitled, “GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells.”In this new study, researchers Michael R. Booth, Laurence Booth, Jane L. Roberts, Cameron West, and Paul Dent from Virginia Commonwealth University and G…

1
Raw Areca Nut Betel Quid Consumption and Esophageal Cancer 6:58

2M ago6:58

6:58

Betel quid chewing, a traditional custom widely practiced in South Asia, Southeast Asia, the Asia-Pacific region, and East Africa for centuries, involves the consumption of raw areca nut mixed with slaked lime and wrapped in a betel leaf. This habit is particularly popular in certain regions, including Northeast India, where the areca nut is raw, w…

1
Combining Causal and Correlative Approaches to Discover Response Biomarkers to Paclitaxel 2:28

2M ago2:28

2:28

BUFFALO, NY- February 21, 2024 – A new research #perspective was #published in Oncotarget's Volume 15 on February 8, 2024, entitled, “Combining causal and correlative approaches to discover biomarkers of response to paclitaxel.”As discussed in this new paper, researchers Alberto Moscona-Nissan, Karl J. Habashy, Victor A. Arrieta, Adam M. Sonabend, …

1
NTRK Gene Fusion in Thyroid Cancer: A Clinicogenomic Biobank and Record Linkage Study From Finland 3:07

2M ago3:07

3:07

BUFFALO, NY- February 19, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on February 5, 2024, entitled, “Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland.”Selective tropomyosin receptor kinase (TRK) inhibitors are approved targeted th…

1
Oncotarget’s Top 10 Papers Published in 2023 (Crossref Data) 5:26

3M ago5:26

5:26

Crossref is a non-profit organization that logs and updates citations for scientific publications. Each month, Crossref identifies a list of the most popular Oncotarget papers based on the number of times a DOI is successfully resolved. Below are Crossref’s Top 10 Oncotarget DOIs published in 2023.10: Everolimus downregulates STAT3/HIF-1α/VEGF path…

1
Genetic and Therapeutic Landscapes in Cohort of Pancreatic Cancer Using NGS and Machine Learning 2:30

3M ago2:30

2:30

BUFFALO, NY- February 14, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on February 5, 2024, entitled, “Genetic and therapeutic landscapes in cohort of pancreatic adenocarcinomas: next-generation sequencing and machine learning for full tumor exome analysis.”About 7% of all cancer deaths are caused by pancreatic cancer (PCa)…

1
Differential Expression of Mad2 Gene in Human Esophageal Cancer 3:02

3M ago3:02

3:02

BUFFALO, NY- February 12, 2024 – A new research paper was published in Oncotarget's Volume 15 on February 5, 2024, entitled, “Differential expression of Mad2 gene is consequential to the patterns of histone H3 post-translational modifications in its promoter region in human esophageal cancer samples.”Raw areca nut (AN) consumption increases esophag…

1
Genetic Alterations in Thyroid Cancer: Resistance to BRAFi and Anaplastic Transformation 10:09

3M ago10:09

10:09

Thyroid cancer is a complex disease with various subtypes and clinical presentations. While some cases can be successfully treated with standard therapy, others present challenges due to resistance to treatment and the development of aggressive forms of the disease. In a new research perspective, researchers Mark Lee and Luc GT Morris from New York…

1
Cross-speciality Perspectives on Practical Management of Atopic Dermatitis-Associated Ocular Surface Diseases 21:28

3M ago21:28

21:28

This podcast is published open access in Dermatology and Therapy and is fully citeable. You can access the original published podcast article through the Dermatology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s13555-023-01093-w. All conflicts of interest can be found online. Open Access This podcast is lic…

1
Evaluation of Ruxolitinib, a Janus Kinase Inhibitor, in Multiple Myeloma 2:38

3M ago2:38

2:38

BUFFALO, NY- February 7, 2024 – A new #research perspective was #published in Oncotarget's Volume 15 on February 5, 2024, entitled, “Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma.”In this new paper, researchers Ashley Del Dosso, Elizabeth Tadevosyan, and James R. Berenson from ONCOtherapeutics, Be…

1
Drug Discovery in Academia; Dumping in the Publication Landfill? 2:51

3M ago2:51

2:51

BUFFALO, NY- February 5, 2024 – A new #editorial paper was #published in Oncotarget's Volume 15 on January 24, 2024, entitled, “The fate of drug discovery in academia; dumping in the publication landfill?”In this new editorial, researchers Uzma Saqib, Isaac S. Demaree, Alexander G. Obukhov, Mirza S. Baig, Amiram Ariel, and Krishnan Hajela, from Dev…

Podcasts Worth a Listen

Osimertinib Podcasts

Podcasts Worth a Listen

Quick Reference Guide